Next Article in Journal / Special Issue
M2e-Based Universal Influenza A Vaccines
Previous Article in Journal
EBV-Associated Cancer and Autoimmunity: Searching for Therapies
Previous Article in Special Issue
Optimal Use of Vaccines for Control of Influenza A Virus in Swine
Open AccessReview

Assaying the Potency of Influenza Vaccines

National Institute for Biological Standards and Control/MHRA, Blanche Lane, Potters Bar, Hertfordshire EN6 3QG, UK
Academic Editor: Sarah Gilbert
Vaccines 2015, 3(1), 90-104; https://doi.org/10.3390/vaccines3010090
Received: 3 November 2014 / Revised: 3 December 2014 / Accepted: 27 January 2015 / Published: 5 February 2015
(This article belongs to the Special Issue Influenza Vaccines)
The potency of vaccines must be determined to ensure that the appropriate dose is given. The manufacture and assessment of influenza vaccines are complicated by the continuously changing nature of the pathogen, which makes efficacy estimates difficult but also confounds attempts to produce a well-validated, consistent potency assay. Single radial diffusion has been used for decades and provides a relatively simple way to measure the amount of biologically active materials present in the vaccine. It requires reagents, which are updated on a regular, frequently yearly, basis and alternative methods continue to be sought. View Full-Text
Keywords: influenza vaccine; potency; SRD; reagent calibration; Influenza Collaborating Centres; Essential Regulatory Laboratories influenza vaccine; potency; SRD; reagent calibration; Influenza Collaborating Centres; Essential Regulatory Laboratories
Show Figures

Figure 1

MDPI and ACS Style

Minor, P.D. Assaying the Potency of Influenza Vaccines. Vaccines 2015, 3, 90-104.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop